Revvity (RVTY) EBIT Growth (1y) (2010 - 2026)
Powered by 
Analysis
Revvity (RVTY) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 13.79% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 48.29% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 23.33% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 14.49% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -1.59% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 411.30% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -5.84% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 0.58% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -164.91% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -648.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | -1.59% |
| Apr 5, 2026 | 5.06% |
| Dec 28, 2025 | -5.90% |
| Sep 28, 2025 | -16.56% |
| Jun 29, 2025 | 5.87% |
| Mar 30, 2025 | 63.73% |
| Sep 29, 2024 | 41.78% |
| Jun 30, 2024 | 9.82% |
| Mar 31, 2024 | -42.04% |
| Oct 1, 2023 | -37.51% |
| Jul 2, 2023 | -66.43% |
| Apr 2, 2023 | -70.94% |
| Jan 1, 2023 | -54.16% |
| Oct 2, 2022 | -43.35% |
| Jul 3, 2022 | -24.51% |
| Apr 3, 2022 | -42.43% |
| Jan 2, 2022 | -41.23% |
| Oct 3, 2021 | -21.15% |
| Jul 4, 2021 | 75.36% |
| Apr 4, 2021 | 918.33% |